Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion
ConclusionBoth RNB and DEX provided a significant resolution in macular oedema. Low frequency injections limited the visual gain in ranibizumab therapy. Visual results could be better with higher frequency injections and early start of treatment. Dexamethasone implants may be preferable in terms of visual improvement under low frequency injection conditions. Close follow‐up is mandatory for detection of intraocular pressure elevations. Laser monotherapy is not a reasonable first‐line option in the era of injection therapies.
Source: Clinical and Experimental Optometry - Category: Opthalmology Authors: Bora Yuksel, Omer Karti, Ozan Celik, Suleyman Gokhan Kerci, Tuncay Kusbeci Tags: Research Source Type: research
More News: Dexamethasone | Eye Implants | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Statistics | Vitamin A